Skip to main content

Peer Review reports

From: Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis

Original Submission
30 Jun 2021 Submitted Original manuscript
26 Jul 2021 Reviewed Reviewer Report
18 Aug 2021 Reviewed Reviewer Report
20 Sep 2021 Author responded Author comments - Kathleen Wilson
21 Sep 2021 Author responded Author comments - Kathleen Wilson
Resubmission - Version 2
20 Sep 2021 Submitted Manuscript version 2
21 Oct 2021 Author responded Author comments - Kathleen Wilson
Resubmission - Version 3
21 Oct 2021 Submitted Manuscript version 3
8 Feb 2022 Author responded Author comments - Kathleen Wilson
Resubmission - Version 4
8 Feb 2022 Submitted Manuscript version 4
29 Mar 2022 Author responded Author comments - Kathleen Wilson
Resubmission - Version 5
29 Mar 2022 Submitted Manuscript version 5
30 Mar 2022 Author responded Author comments - Kathleen Wilson
Resubmission - Version 6
30 Mar 2022 Submitted Manuscript version 6
5 Apr 2022 Author responded Author comments - Kathleen Wilson
Resubmission - Version 7
5 Apr 2022 Submitted Manuscript version 7
12 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
27 May 2022 Editorially accepted
7 Jun 2022 Article published 10.1186/s12883-022-02738-7

You can find further information about peer review here.

Back to article page